伴神经内分泌特征的浸润性乳腺癌一例及文献复习
查看参考文献17篇
|
文摘
|
伴神经内分泌特征的浸润性乳腺癌(invasive breat carcinoma with neuroendocrine features,BCNF)是一种特殊类型的乳腺癌。2012版《WHO乳腺肿瘤分类》对BCNF的命名、定义及组织学分类作出了一定的修改,使得BCNF在组织学上更加多样,导致其病理诊断具有一定的难度,往往需要通过其神经内分泌的免疫组织化学标志物才能明确诊断;并且,在乳腺粗针穿刺活组织检查(简称活检)时,对其进行诊断更为困难。笔者通过分析1例经乳腺粗针穿刺活检诊断为BCNF患者的临床资料及文献回顾来探讨BCNF的临床病理学特征。 |
|
来源
|
中华乳腺病杂志（电子版）
,2018,12(4):250-252 【扩展库】
|
|
DOI
|
10.3877/cma.j.issn.1674-0807.2018.04.012
|
|
关键词
|
乳腺肿瘤
;
神经内分泌
;
诊断
|
|
地址
|
成都市妇女儿童中心医院病理科, 610000
|
|
语种
|
中文 |
|
文献类型
|
简报 |
|
ISSN
|
1674-0807 |
|
学科
|
肿瘤学 |
|
文献收藏号
|
CSCD:6320791
|
参考文献 共
17
共1页
|
|
1.
Lakhani S R.
WHO classification of tumours of the breast. 4 ed,2012
|
CSCD被引
1
次
|
|
|
|
|
2.
Mohanty S K. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
Mod Pathol,2016,29(8):788-798
|
CSCD被引
2
次
|
|
|
|
|
3.
Adams R W. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast?.
Breast,2014,23(2):120-127
|
CSCD被引
2
次
|
|
|
|
|
4.
Tavassoli F A. World Health Organization classification oftumours.
Pathology and genetics of tumours. Pathology and genetics of tumours of the breast and femalegenital organs,2003
|
CSCD被引
1
次
|
|
|
|
|
5.
Tang F. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
Histopathology,2011,59(1):106-115
|
CSCD被引
2
次
|
|
|
|
|
6.
van Krimpen C. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study.
Breast,2004,13(4):329-333
|
CSCD被引
1
次
|
|
|
|
|
7.
Wang J. Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance,epidemiology and end results (SEER) database.
BMC Cancer,2014,14:147
|
CSCD被引
7
次
|
|
|
|
|
8.
Maluf H M. Carcinomas of the breast with endocrine differentiation: a review.
Virchows Archiv,1994,425(5):449-457
|
CSCD被引
9
次
|
|
|
|
|
9.
Nesland J M. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
Histol Histopathol,1987,2(1):73-77
|
CSCD被引
1
次
|
|
|
|
|
10.
Kawasaki T. Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance.
J Clin Pathol,2012,65(8):699-703
|
CSCD被引
3
次
|
|
|
|
|
11.
Chan J. Targeting the mTOR signaling pathway in neuroendocrine tumors.
Curr Treat Options Oncol,2014,15(3):365-379
|
CSCD被引
2
次
|
|
|
|
|
12.
Righi L. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
Semin Diagn Pathol,2010,27(1):69-76
|
CSCD被引
8
次
|
|
|
|
|
13.
Asioli S. Working formulation of neuroendocrine tumors of the skin and breast.
Endocr Pathol,2014,25(2):141-150
|
CSCD被引
1
次
|
|
|
|
|
14.
Bogina G. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
Histopathology,2016,68(3):422-432
|
CSCD被引
5
次
|
|
|
|
|
15.
Kawasaki T. High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge.
Breast,2012,21(5):652-656
|
CSCD被引
3
次
|
|
|
|
|
16.
Inno A. Neuroendocrine carcinoma of the breast: Current evidence and future perspectives.
Oncologist,2016,21(1):28-32
|
CSCD被引
5
次
|
|
|
|
|
17.
朱坤兵. 乳腺癌分子分型与新辅助化疗效果的关系.
中华乳腺病杂志:电子版,2016,10(3):166-169
|
CSCD被引
4
次
|
|
|
|
|
了解气象卫星更多信息，请访问